{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T01:19:03Z","timestamp":1773883143239,"version":"3.50.1"},"reference-count":35,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100014386","name":"Abbott | Abbott Diagnostics","doi-asserted-by":"publisher","award":["Partial kit cost"],"award-info":[{"award-number":["Partial kit cost"]}],"id":[{"id":"10.13039\/100014386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009192","name":"Alberta Innovates","doi-asserted-by":"publisher","award":["G2020000360Drews"],"award-info":[{"award-number":["G2020000360Drews"]}],"id":[{"id":"10.13039\/501100009192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009192","name":"Alberta Innovates","doi-asserted-by":"publisher","award":["G2020000360Drews"],"award-info":[{"award-number":["G2020000360Drews"]}],"id":[{"id":"10.13039\/501100009192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009192","name":"Alberta Innovates","doi-asserted-by":"publisher","award":["G2020000360Drews"],"award-info":[{"award-number":["G2020000360Drews"]}],"id":[{"id":"10.13039\/501100009192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["VR2-172723"],"award-info":[{"award-number":["VR2-172723"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["VR2-172723"],"award-info":[{"award-number":["VR2-172723"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["VR2-172723"],"award-info":[{"award-number":["VR2-172723"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2022,2,23]]},"abstract":"<jats:p>Here, we describe an approach to estimating seroprevalence in a low prevalence setting when multiple assays are available and yet no known gold standard exists. Because serological studies identify cases through both diagnostic testing and surveillance, and otherwise silent, unrecognized infections, serological data can be used to estimate the true infection fatality ratio of a disease.<\/jats:p>","DOI":"10.1128\/spectrum.02563-21","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T21:34:14Z","timestamp":1645652054000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":13,"title":["Estimating SARS-CoV-2 Seroprevalence in Canadian Blood Donors, April 2020 to March 2021: Improving Accuracy with Multiple Assays"],"prefix":"10.1128","volume":"10","author":[{"given":"Ashleigh R.","family":"Tuite","sequence":"first","affiliation":[{"name":"Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada"},{"name":"Centre for Immunization Readiness, Public Health Agency of Canada, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Fisman","sequence":"additional","affiliation":[{"name":"Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kento T.","family":"Abe","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute at Mt. Sinai Hospital, Sinai Health, Toronto, Ontario, Canada"},{"name":"Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavisha","family":"Rathod","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute at Mt. Sinai Hospital, Sinai Health, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Pasculescu","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute at Mt. Sinai Hospital, Sinai Health, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Colwill","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute at Mt. Sinai Hospital, Sinai Health, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Claude","family":"Gingras","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute at Mt. Sinai Hospital, Sinai Health, Toronto, Ontario, Canada"},{"name":"Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-Long","family":"Yi","sequence":"additional","affiliation":[{"name":"Epidemiology and Surveillance, Canadian Blood Services, Ottawa, Ontario, Canada"},{"name":"School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila F.","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"Epidemiology and Surveillance, Canadian Blood Services, Ottawa, Ontario, Canada"},{"name":"School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2519-1109","authenticated-orcid":true,"given":"Steven J.","family":"Drews","sequence":"additional","affiliation":[{"name":"Canadian Blood Services, Microbiology, Edmonton, Alberta, Canada"},{"name":"Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.15161"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257743"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0000000000001361"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2020.06.011"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.3138\/jammi-2021-0323"},{"key":"e_1_3_2_7_2","unstructured":"Government of Canada. 2021. Coronavirus disease (COVID-19): Outbreak update. https:\/\/www.canada.ca\/en\/public-health\/services\/diseases\/2019-novel-coronavirus-infection.html?utm_campaign=hc-sc-phm-21-22&utm_medium=sem&utm_source=ggl&utm_content=ad-text-en&utm_term=coronavirus%20update%20canada&adv=2122-0008&id_campaign=12663296824&id_source=125900518968&id_content=511624188952&gclid=Cj0KCQiA-eeMBhCpARIsAAZfxZDaNLkoO11qdPc3fXEVj_OsKpKvN82TwvcUQugL-YzSVe8rrLhYAxQaAndjEALw_wcB&gclsrc=aw.ds. Last accessed 2022-01-05."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16296"},{"key":"e_1_3_2_9_2","unstructured":"Aiello R. 2021. 'V-Day': First COVID-19 vaccines administered in Canada. CTV News Ottawa. https:\/\/www.ctvnews.ca\/health\/coronavirus\/v-day-first-covid-19-vaccines-administered-in-canada-1.5230184. Accedded 2022\u201301-05."},{"key":"e_1_3_2_10_2","unstructured":"Canada Go. 2021. COVID-19 vaccination in Canada 2021. https:\/\/health-infobase.canada.ca\/covid-19\/vaccination-coverage\/. Accessed 2022-01-05."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02262-21"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06202-8"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.7326\/M20-7003"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02144-9"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1101\/2021.10.06.21264573"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2021.101518"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2021.115412"},{"key":"e_1_3_2_18_2","first-page":"10","article-title":"Waning anti-nucleocapsid IgG signal among SARS-CoV-2 seropositive blood donors: May\u2013November 2020","volume":"6","author":"Saeed S","year":"2021","unstructured":"Saeed S, Drews SJ, Pambrun C, O'Brien SF. 2021. Waning anti-nucleocapsid IgG signal among SARS-CoV-2 seropositive blood donors: May\u2013November 2020. JAMMI 6:10\u201311.","journal-title":"JAMMI"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9101092"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16713"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16364"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.142362"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-7-23"},{"key":"e_1_3_2_24_2","unstructured":"Government of Canada. 2021. SARS-CoV-2 variants: National definitions classifications and public health actions. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/diseases\/2019-novel-coronavirus-infection\/health-professionals\/testing-diagnosing-case-reporting\/sars-cov-2-variants-national-definitions-classifications-public-health-actions.html. Accessed January 5 2022."},{"key":"e_1_3_2_25_2","unstructured":"O'Brien SF. 2021. Canadian Blood Services. Personal communication. unpublished."},{"key":"e_1_3_2_26_2","unstructured":"Statistics Canada S. 2021. Few Canadians had antibodies against SARS-CoV-2 in early 2021. Available from: https:\/\/www150.statcan.gc.ca\/n1\/daily-quotidien\/210706\/dq210706a-eng.htm. Accessed December 8 2021."},{"key":"e_1_3_2_27_2","unstructured":"COVID-19 Immunity Task Force. 2021. Recent blood donor data suggest that Canadians still remain vulnerable to SARS-CoV-2 infection. 2021. 05\u201327. https:\/\/www.covid19immunitytaskforce.ca\/recent-blood-donor-data-suggest-that-canadians-still-remain-vulnerable-to-sars-cov-2-infection\/. Accessed January 5 2022."},{"key":"e_1_3_2_28_2","unstructured":"Government of Canada. 2022. COVID-19 daily epidemiology update. https:\/\/health-infobase.canada.ca\/covid-19\/epidemiological-summary-covid-19-cases.html. Accessed January 5 2022."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.211248"},{"key":"e_1_3_2_30_2","unstructured":"National Collaborating Centre for Infectious Diseases. 2021. Updates on COVID-19 Variants of Concern. https:\/\/nccid.ca\/covid-19-variants\/#subMenuSection0. Accessed January 5 2022."},{"key":"e_1_3_2_31_2","unstructured":"COVID-19 Immunity Task Force. 2021. Vaccine-induced seroprevalence hits highest level to date yet early fourth wave hitting those most at-risk: Canadian Blood Services. https:\/\/www.covid19immunitytaskforce.ca\/vaccine-induced-seroprevalence-hits-highest-level-to-date-yet-early-fourth-wave-hitting-those-most-at-risk-canadian-blood-services-august-report\/. Accessed January 5 2022."},{"key":"e_1_3_2_32_2","unstructured":"Canadian Blood Services Surveillance Report. 2019. Available from: https:\/\/professionaleducation.blood.ca\/en\/transfusion\/publications\/surveillance-report. Accessed December 8 2021."},{"key":"e_1_3_2_33_2","article-title":"Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workers","author":"Abe K","year":"2021","unstructured":"Abe K, Hu Q, Mozafarihashjin M, Samson R, Manguiat K, Robinson A, et al. 2021. Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workers. medRxiv.","journal-title":"medRxiv"},{"key":"e_1_3_2_34_2","article-title":"A \u201cMade-in-Canada\u201d serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination","author":"Colwill K","year":"2021","unstructured":"Colwill K, Galipeau Y, Stuible M, Gervais C, Arnold C, Rathod B, et al. 2021. A \u201cMade-in-Canada\u201d serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination. medRxiv. 2021.10.25.21265476.","journal-title":"medRxiv"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v061.i13"},{"key":"e_1_3_2_36_2","unstructured":"R Core Team. 2021. R: A language and environment for statistical computing. R Foundation for Statistical Computing. Vienna Austria. https:\/\/www.R-project.org\/."}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.02563-21","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.02563-21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T08:48:10Z","timestamp":1646729290000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.02563-21"}},"subtitle":[],"editor":[{"given":"David T.","family":"Pride","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,2,23]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2,23]]}},"alternative-id":["10.1128\/spectrum.02563-21"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.02563-21","relation":{},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,23]]},"assertion":[{"value":"2021-12-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e02563-21"}}